Skip to main content
Mabion S.A. logo

Mabion S.A. — Investor Relations & Filings

Ticker · MAB ISIN · PLMBION00016 LEI · 259400KG5JVQPPZL6X53 WAR Manufacturing
Open in API
Filings indexed 1,002 across all filing types
Latest filing 2021-03-03 Board/Management Inform…
Country PL Poland
Listing WAR MAB

About Mabion S.A.

https://www.mabion.eu/en/

Mabion S.A. is an integrated Contract Development and Manufacturing Organization (CDMO) that provides end-to-end services for the development and manufacturing of protein-based biotherapeutics. The company specializes in monoclonal antibodies and biosimilars, offering a complete workflow from cell line development and banking to process optimization and large-scale GMP manufacturing. Core competencies include upstream processing using mammalian cell cultures, downstream purification involving chromatography and viral clearance, and technology transfer for scale-up. Mabion partners with pharmaceutical and biotechnology companies to support both clinical and commercial supply, streamlining the path from gene to final drug product.

Recent filings

Filing Released Lang Actions
Zmiany w składzie Zarządu i Rady Nadzorczej Spółki - Content (EN)
Board/Management Information Classification · 100% confidence The document explicitly announces changes in the composition of the Management Board and Supervisory Board, detailing the resignation of one member from the Supervisory Board and their simultaneous appointment to the Management Board. This directly aligns with the definition of 'Board/Management Information' (MANG), which covers announcements of changes in the company's board of directors or senior management.
2021-03-03 English
Zmiany w składzie Zarządu i Rady Nadzorczej Spółki - Content (PL)
Board/Management Information Classification · 99% confidence The document text is an official announcement from the Management Board ('Zarząd') of Mabion S.A. It details the resignation of Mr. Adam Pietruszkiewicz from the Supervisory Board ('Rada Nadzorcza') and his immediate appointment to the Management Board ('Zarząd'). It also provides biographical and conflict-of-interest information about the newly appointed board member. This content directly relates to changes in the company's senior management and board structure. This aligns perfectly with the definition for Board/Management Information (MANG). The document is short and is an announcement, not a comprehensive report.
2021-03-03 Polish
Powiadomienie Krzysztof Kaczmarczyk
Director's Dealing Classification · 100% confidence The document is titled "Powiadomienie o transakcji/transakcjach*, o którym mowa w art. 19 ust. 1 rozporządzenia MAR" (Notification of a transaction/transactions referred to in Article 19(1) of the MAR Regulation). It details a transaction involving shares ('Akcje') by a member of the Supervisory Board ('Członek Rady Nadzorczej') of Mabion Spółka Akcyjna. Specifically, it reports the 'Nabycie' (Acquisition) of shares by an insider. This type of mandatory disclosure regarding personal share transactions by directors and executives falls directly under the definition of Director's Dealing (DIRS).
2021-03-03 Polish
Powiadomienie o transakcjach na akcjach Mabion S.A. dokonanych przez osobę pełniącą obowiązki zarządcze - Content (EN)
Director's Dealing Classification · 100% confidence The document explicitly states it is a 'Notification of transactions on Mabion S.A. shares performed by the person discharging managerial responsibilities' and cites 'Art. 19 par. 3 MAR'. This directly corresponds to reporting insider transactions by directors or executives. The most specific category for this is 'Director's Dealing' (DIRS). The document is short and reports on transactions made by a specific individual (Chairman of the Supervisory Board).
2021-03-03 English
Powiadomienie o transakcjach na akcjach Mabion S.A. dokonanych przez osobę pełniącą obowiązki zarządcze - Content (PL)
Director's Dealing Classification · 100% confidence The document text is very short (341 characters) and explicitly states that the Management Board ('Zarząd') received a notification ('powiadomienie') from a person holding a management position ('osoby pełniącej obowiązki zarządcze'), specifically the Chairman of the Supervisory Board ('Przewodniczącego Rady Nadzorczej'), regarding transactions made on the company's shares ('transakcjach dokonanych na akcjach Spółki'). It concludes by stating the content of the notification is attached to the report ('Treść powiadomienia Spółka przekazuje w załączeniu do niniejszego raportu'). This structure—a brief announcement referencing an attached document detailing insider transactions—strongly suggests a Director's Dealing report notification. The corresponding code is DIRS.
2021-03-03 Polish
Zawarcie porozumienia z Polskim Funduszem Rozwoju S.A. - Content (EN)
Capital/Financing Update Classification · 95% confidence The document is a formal announcement titled 'Subject matter: Conclusion of a preliminary agreement...' and explicitly cites 'Legal basis: Article 17(1) MAR - confidential information.' This structure is characteristic of a regulatory disclosure made under the Market Abuse Regulation (MAR) concerning material, non-public information. The content details a potential investment (financing/capital structure change) and cooperation related to vaccine production. Since it is a direct, material announcement rather than a summary of results (ER) or a report itself (10-K, IR), and it concerns a significant financial/capital event (PLN 40 million investment), it fits best under Capital/Financing Update (CAP). While it involves financing, it is a specific announcement of a preliminary agreement, not a general regulatory filing fallback (RNS).
2021-03-03 English

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.